These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 25180725)
21. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy. Lu M; Xia ZY; Bao L Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251 [TBL] [Abstract][Full Text] [Related]
22. Current perspective in tuberculosis vaccine development for high TB endemic regions. Husain AA; Daginawala HF; Singh L; Kashyap RS Tuberculosis (Edinb); 2016 May; 98():149-58. PubMed ID: 27156631 [TBL] [Abstract][Full Text] [Related]
23. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines. Mascart F; Locht C Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361 [TBL] [Abstract][Full Text] [Related]
24. Novel vaccination strategies and approaches against human tuberculosis. Méndez-Samperio P Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193 [TBL] [Abstract][Full Text] [Related]
25. Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments. Lai R; Afkhami S; Haddadi S; Jeyanathan M; Xing Z Eur Respir Rev; 2015 Jun; 24(136):356-60. PubMed ID: 26028646 [TBL] [Abstract][Full Text] [Related]
26. Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Jeyanathan M; Heriazon A; Xing Z Trends Immunol; 2010 Jul; 31(7):247-52. PubMed ID: 20542470 [TBL] [Abstract][Full Text] [Related]
27. Mouse and guinea pig models for testing new tuberculosis vaccines. Orme IM Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022 [TBL] [Abstract][Full Text] [Related]
32. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
33. [BCG vaccines for the prevention of tuberculosis in the world]. Hashimoto T Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301 [TBL] [Abstract][Full Text] [Related]
34. Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis. Kaufmann SH; Baumann S; Nasser Eddine A Int J Tuberc Lung Dis; 2006 Oct; 10(10):1068-79. PubMed ID: 17044198 [TBL] [Abstract][Full Text] [Related]
35. Tuberculosis vaccine development at a divide. Kaufmann SH Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237 [TBL] [Abstract][Full Text] [Related]
36. Bacille Calmette Guérin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects. Fritschi N; Curtis N; Ritz N Paediatr Respir Rev; 2020 Nov; 36():57-64. PubMed ID: 32958428 [TBL] [Abstract][Full Text] [Related]
37. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035 [TBL] [Abstract][Full Text] [Related]
38. Aerosol immunisation for TB: matching route of vaccination to route of infection. Manjaly Thomas ZR; McShane H Trans R Soc Trop Med Hyg; 2015 Mar; 109(3):175-81. PubMed ID: 25636950 [TBL] [Abstract][Full Text] [Related]
39. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis. Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436 [TBL] [Abstract][Full Text] [Related]
40. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting. Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]